WALTHAM, Mass. & VIENNA, Austria--(BUSINESS WIRE)--Arsanis, Inc., a clinical-stage biopharmaceutical company focused on monoclonal antibody approaches for the prevention and treatment of serious infectious diseases, today announced that René Russo, PharmD, BCPS, chief development officer, will present a company overview at the Cowen and Company 36th Annual Health Care Conference in Boston.
